Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. Geyer CE Jr, Untch M, Huang CS, Mano MS, et al. N Engl J Med 2025;392:249-257.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Geyer CE Jr, Untch M, Huang CS, Mano MS, et al. Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. N Engl J Med 2025;392:249-257.
PMID: 39813643